As of Jan 2026 ยท from Reg CF Offering (2025) ยท pre-money + amount raised, not a traded price
Total raised
$2,400,475
Across 4 rounds since 2022
Latest share price
$0.55
Reg CF Offering (2025) offering price
Financials
FY2020โFY2025 ยท from SEC filings ยท hover any figure for its source
$3.9M
โ$1.4M
2020
$3.3M
โ$1.6M
2021
$3.1M
โ$2.0M
2022
$2.6M
โ$1.5M
2023
$4.2M
โ$759K
2024
$5.5M
$615K
2025
RevenueNet income โ beside revenue when positive, below the line when a loss
Metric
FY2020
FY2021
FY2022
FY2023
FY2024
FY2025
Income statement
Revenue
$3,904,356
$3,280,014
$3,090,690
$2,571,791
$4,178,639
$5,486,899
Cost of goods sold
$993,933
$865,404
$835,763
$646,082
$1,002,183
$1,263,414
Gross margin
75%
74%
73%
75%
76%
77%
Net income
-$1,423,109
-$1,554,407
-$1,981,929
-$1,452,776
-$758,795
$615,350
Taxes paid
$1,600
$1,664
$0
$2,425
$1,600
$1,600
Balance sheet
Cash
$4,344,596
$2,549,130
$960,306
$593,842
$764,561
$876,585
Accounts receivable
$480,618
$146,277
$356,975
$422,597
$0
$738,882
Total assets
$4,891,929
$2,769,557
$1,404,294
$1,233,685
$937,946
$1,745,192
Short-term debt
$796,261
$465,365
$0
$0
$0
$0
Long-term debt
$237,070
$0
$0
$0
$0
$0
Total liabilities
$1,033,331
$465,365
$0
$0
$0
$0
Other
Headcount
โ
15
15
10
15
15
Figures as reported by the issuer in the filing shown on hover. Each yearโs pill shows the assurance level of its filed statements โ audited, reviewed (CPA review, less than an audit), or unaudited; no pill means the filing didnโt state one. Headcount is the filingโs point-in-time count, not a year-end average. Manually corrected figures are marked โCorrectedโ.
A dashed amber step is a SAFE/note valuation cap โ a conversion ceiling agreed for that instrument, not a priced valuation of the company. Steps are not comparable across bases.
About this data. Figures are compiled from public sources โ SEC EDGAR filings (Form C, C-AR, 1-A, 1-K) and funding-platform pages โ and may be delayed, incomplete, or restated by the issuer. Financial statements are as reported by the issuer; each year is labeled with its assurance level (audited / reviewed / unaudited). A valuation cap is the conversion ceiling of a SAFE or convertible note, not an agreed company valuation; post-money figures are computed as pre-money plus amount raised and are not a traded price. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.